首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Clinical outcomes of peritoneal dialysis patients transferred from hemodialysis: A matched case-control study
【24h】

Clinical outcomes of peritoneal dialysis patients transferred from hemodialysis: A matched case-control study

机译:血液透析后腹膜透析患者的临床结局:病例对照研究

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: Our study aimed to evaluate clinical outcomes of patients transferred to peritoneal dialysis (PD) because of complications related to hemodialysis (HD). Methods: In a 1:2 matched case-control study, we compared patient and technique survival between patients initially treated with HD for at least 3 months and then transferred to PD (transfer group) and patients started on and continuing with PD (no-transfer group). Results: All baseline characteristics except for initial residual urinary output were comparable between the groups. Compared with patients in the transfer group, patients in the no-transfer group had a higher initial daily residual urinary output [850 mL (range: 600 - 1250 mL) vs 0 mL (range: 0 - 775 mL/d), p = 0.000]. The main reasons for transfer to PD were vascular access problems and cardiovascular disease. Patient survival and technique failure rates did not significantly differ between the groups (p > 0.05). The 1-, 3-, and 5-year patient survival rates were 80.0%, 53.7%, and 27.6% in the transfer group and 89.7%, 60.2%, and 43.1% in the no-transfer group. Age (per 10 years) and serum albumin were independent risk factors for long-term survival in PD patients. Relative risk of either death or technique failure was not significantly increased in patients transferred from HD. Conclusions: Patients who transferred to PD after failing HD had outcomes on PD similar to those for patients who started with and were maintained on PD. Age (per 10 years) and serum albumin were independent risk factors for long-term survival in PD patients.
机译:目的:我们的研究旨在评估因血液透析(HD)相关并发症而转移至腹膜透析(PD)的患者的临床结局。方法:在1:2配对病例对照研究中,我们比较了最初接受HD治疗至少3个月,然后转移至PD(转移组)和开始并继续PD(无转移组)。结果:除初始残余尿量外,所有基线特征在各组之间均具有可比性。与转运组患者相比,无转运组患者的初始每日残余尿量更高[850 mL(范围:600-1250 mL)对0 mL(范围:0-775 mL / d),p = 0.000]。转移至PD的主要原因是血管通路问题和心血管疾病。两组之间的患者生存率和技术失败率无显着差异(p> 0.05)。转移组的1、3和5年患者生存率分别为80.0%,53.7%和27.6%,无转移组的分别为89.7%,60.2%和43.1%。年龄(每10年)和血清白蛋白是PD患者长期生存的独立危险因素。从HD转移的患者中,死亡或技术失败的相对风险没有显着增加。结论:HD失败后转入PD的患者的PD结局类似于开始并维持PD的患者。年龄(每10年)和血清白蛋白是PD患者长期生存的独立危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号